European Regulators Propose Hemoglobin Target Range For Anemia Therapies
This article was originally published in The Pink Sheet Daily
Executive Summary
Proposed EPO labeling that sets target hemoglobin levels in 10-12 g/dL range is consistent with European prescribing practices, analysts note.
You may also be interested in...
European Regulators Approve Labeling Update For Amgen’s Aranesp
Revised European ESA prescribing information consistent with proposal released last fall.
European Regulators Approve Labeling Update For Amgen’s Aranesp
Revised European ESA prescribing information consistent with proposal released last fall.
Amgen, J&J Revise Labels For Aranesp, Epogen, Procrit
Amgen says it will present new data to CMS in effort to persuade agency to modify its National Coverage Decision on ESAs.